The use of methotrexate for treatment of psoriasis in patients with HIV infection.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8034807.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The use of methotrexate (MTX) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and accelerate HIV disease. We describe three HIV-infected patients who were given MTX for severe psoriatic arthritis. In two patients opportunistic infections did not develop. On the basis of survival data, it is not clear that use of MTX adversely affected the natural course of their HIV disease.
Medical subject headings
- Arthritis, Psoriatic
- HIV Infections
- Methotrexate